Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-106752

Interim CEO & General Counsel gave up 6,638 shares (to pay taxes)

  • Interim CEO & General Counsel acquired 15,626 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Vogt Frederick G Interim CEO & General Counsel 2026-09-08 Option exercise +15,626 602,085 D: show line 1 in the form
Vogt Frederick G Interim CEO & General Counsel 2026-09-08 Shares withheld for taxes −6,638 $8.70 $57,751 595,447 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Vogt Frederick G Interim CEO & General Counsel 2026-09-08 Option exercise · Restricted Stock Units −15,626 93,756 D: show line 3 in the form
Loading xslF345X06/tm2625111-3_4seq1.xml…